Ironwood Pharmaceuticals | IRWD - 债务



金融业
股票价格
USD
资产
USD 434.57M
现金及等价物
USD 220.47M
销售成本
USD 29.83M
流动资产
USD 332.29M
流动负债
USD 236.31M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.31
股本和储备
USD -217.14M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 641.8M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 113.04M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.24M
应收帐款人
USD 81.89M


债务 更改 日
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Agios Pharmaceuticals USD 35.74M 4.46M 2026-03
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Almirall EUR 342.86M 61.94M 2025-12
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amarin USD 0 0 2025-03
Ardelyx USD 208.26M 653K 2026-03
Astellas Pharma JPY 565.95B 265.47B 2026-03
AstraZeneca USD 32.24B 1.68B 2026-06
Charles River Laboratories USD 3.06B 485.84M 2026-03
Coherus Biosciences USD 294.92M 1.25M 2025-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Incyte USD 38.27M 1.16M 2026-06
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
MacroGenics USD 36.51M 500K 2026-03
Moderna USD 1.3B 7M 2026-03
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacira USD 363.12M 4.53M 2026-06
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Takeda JPY 4.94T 58.13B 2026-06
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12